ActiveGRANT
Nanobody against NPR-C for growth disorder
NATIONAL INSTITUTES OF HEALTHHEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH OLAO
AI Overview
NIH R&D contract for nanobody development against NPR-C targeting growth disorder therapeutics. Includes antigen generation, alpaca/llama immunization, phage/yeast display library screening, and VHH-Fc candidate development.
This summary is AI-generated from the official solicitation.
Key Details
Agency
NATIONAL INSTITUTES OF HEALTH
Funding Amount
—
Release Date
August 18, 2026
Due Date
August 28, 2026
Official Description
See attached Word document. Project Title: Nanobody against NPR-C for growth disorder
- Project Overview 1.1 Background We sought to develop nanobodies (VHH) against human NPR-C with high affinity and specificity for future clinical use. These nanobodies could potentially be further developed into therapeutics for treatment of growth disorders such as achondroplasia. 1.2 Main Objectives - generation of antigens needed for immunization - immunization of Alpaca/Ilama with target antigens generate...
Change History
Opportunity AddedAug 18, 2026 at 9:03 PM
Nanobody against NPR-C for growth disorder
New SAM.gov opportunity: Nanobody against NPR-C for growth disorder
Similar Opportunities
Forecast
REQUEST FOR WHITE PAPERS BAA TOPIC: Topic 13. Biotechnology, “Controlling polymicrobial environments as a strategy for defeating harmful organisms while promoting the growth of beneficial organisms”
Due August 31, 2026
Pre-ReleaseUniversal Cell Culture Platform for Rapid Establishment of Species-Agnostic Cell Lines and Autonomous Culture Operations
Due September 23, 2026
ActivePortfolio Acquisition Executive - Marine Corps (PAE-MC) Ground Combat Vehicle Testing, Research, and Development
Due August 28, 2026
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial